Jim’s 25 years of pharmaceutical industry experience have been focused primarily on product launches, pricing strategy, and account management. He has served in roles of increasing responsibility dedicated to improving patient access to life changing therapies.
Jim joined Pharmacosmos Therapeutics in March of 2020 as Vice President, Market Access. He was appointed Sr. Vice President, Market Access in May 2022. Previously, Jim was Executive Director of Pricing and Contracting at Celgene.
Jim holds a Master of Business Administration in Accounting from St. Joseph’s University and a Bachelor of Business Administration in Finance from Temple University.
You are now leaving Pharmacosmos.us. The website you are about to visit is Pharmacosmos Headquarter or one of our subsidiaries.
Do you wish to proceed?